LABORATORIO FARMAC.ERFO (RK7) — Capital Reinvestment Ratio
Latest as of December 2023:
1.11x
LABORATORIO FARMAC.ERFO (RK7) has a Capital Reinvestment Ratio of 1.11x as of December 2023, meaning it reinvests 1% of its operating cash flow (€1.30 Million) in capital expenditures (€1.45 Million). See LABORATORIO FARMAC.ERFO free cash flow ratio to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
1.11x
Capex / Operating Cash Flow
Operating Cash Flow
€1.30 Million
EUR
Capital Expenditures
€1.45 Million
EUR
Data as of
Dec 2023
Most recent filing
LABORATORIO FARMAC.ERFO Capital Reinvestment Ratio (2021–2023)
This chart tracks LABORATORIO FARMAC.ERFO's Capital Reinvestment Ratio across 3 annual periods.
Annual Capital Reinvestment Ratio for LABORATORIO FARMAC.ERFO (2021–2023)
Year-by-year Capital Reinvestment Ratio for LABORATORIO FARMAC.ERFO from 2021 to 2023. For live market cap and broader valuation context, see LABORATORIO FARMAC.ERFO (RK7) market capitalisation.
| Year | Reinvestment Ratio | Operating CF (EUR) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2023 | 1.11x | €1.30 Million | €1.45 Million | ▼ -27.9% |
| 2022 | 1.55x | €761.80K | €1.18 Million | ▲ +1347.6% |
| 2021 | 0.11x | €2.27 Million | €242.84K | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow